Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of Alzheimer's disease

US Patent 10071963 · Granted Sep 11, 2018

Assignee

Inventors

View full patent text on Google Patents →